Current role
Kenneth C. Cundy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth C. Cundy
The proxy statement of Anebulo Pharmaceuticals, Inc. reports total compensation of $490,357 for Kenneth C. Cundy in fiscal 2022, including a base salary of $39,936.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Anebulo Pharmaceuticals, Inc. (ANEB)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anebulo Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Richard (Richie) Anthony Cunningham CEO, Board Member
- Richard Anthony Cunningham CEO, Board Member
- Daniel George CFO, Chief Accounting Officer
- Sandra A. Gardiner CFO, Chief Accounting Officer
- Aron R. English Board Member
- Bimal Shah Board Member
- Joseph F. Lawler Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Anebulo Pharmaceuticals, Inc. (ANEB) | Chief Scientific Officer | $39,936 | $490,357 |
Recent activity
No call appearances or filed executive changes recorded yet.